LexisNexis® Legal Newsroom
The FDA Goes Gluten-Free: Let's Speed It Up

The FDA's final rule on gluten-free labeling was published in the Federal Register on August 5, 2013, with a mandatory date for compliance of one year thereafter, or August 5, 2014. But the FDA makes clear that this is an outside date. "However, as stated, FDA anticipates that manufacturers...

Norton Rose Fulbright Consumer Products Law Blog: Formula For Disaster: FTC Sues Gerber For Falsely Advertising Baby Formula As ‘’FDA Approved’

By Julie Glazer Last week the FTC sued Gerber Products Co., alleging that it has no basis for asserting that its Good Start Gentle baby formula reduces the risk of infant allergy development and that these health claims were falsely advertised as “FDA Approved.” Whether to identify...

FDA is Keeping up with Kim Kardashian

by Cori Goldberg and Saul Perloff Kim Kardashian’s recent Instagram post yielded 466,000 “likes” and one FDA Warning Letter . In her social media post, also posted on Facebook, Kardashian discussed the drug DICLEGIS and the positive effect she claims it has had on her morning sickness...

Kim Kardashian Posts Corrective Ad on Instagram

Kim Kardashian is promoting Diclegis® on social media once again. But this time, she is posting about the drug to correct her prior actions. On August 12, we discussed Kim Kardashian’s Instagram and Facebook post in which she discussed the drug Diclegis® and the positive effect that...

Duane Morris LLP: FDA Publishes Revised Guidance on Product Tracing Requirements for Dispensers

On November 27, 2013, the Drug Supply Chain Security Act (DSCSA) was enacted “to build an electronic, interoperable system by November 27, 2023, which will identify and trace certain prescription drugs as they are distributed in the United States.” This year, trading partners were required...

Duane Morris LLP: FDA Publishes Draft Guidance Documents on Compounding Using Bulk Drug Substances

On October 27, 2015, the U.S. Food and Drug Administration (FDA) published notice of two draft guidance documents in the Federal Register [1] : “Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act” [2] and “Interim...